Twist Bioscience (TWST) Total Non-Current Liabilities (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Total Non-Current Liabilities data on file, last reported at $220.4 million in Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $220.4 million, up 42.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $220.4 million (up 42.13% YoY), and the FY2025 annual result was $168.2 million, up 19.07% from the prior year.
• Total Non-Current Liabilities improved to $220.4 million in Q1 2026 per TWST's latest filing, from $181.2 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $220.4 million in Q1 2026 and troughed at $141.2 million in Q3 2024.
• A 5-year average of $159.5 million and a median of $152.7 million in 2023 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities soared 831.33% in 2022, then fell 13.01% in 2023.
• A 5-year view of Total Non-Current Liabilities shows it stood at $163.6 million in 2022, then dropped by 13.01% to $142.3 million in 2023, then climbed by 6.98% to $152.2 million in 2024, then increased by 19.06% to $181.2 million in 2025, then grew by 21.59% to $220.4 million in 2026.
• Business Quant data shows TWST's Total Non-Current Liabilities at $220.4 million in Q1 2026, $181.2 million in Q4 2025, and $168.2 million in Q3 2025.